[
    [
        {
            "time": "",
            "original_text": "健帆生物预计2019年盈利5.23亿元-6.03亿元，同比增长30%-50%",
            "features": {
                "keywords": [
                    "健帆生物",
                    "2019年",
                    "盈利",
                    "5.23亿元",
                    "6.03亿元",
                    "同比增长",
                    "30%",
                    "50%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "健帆生物预计2019年盈利5.23亿元-6.03亿元，同比增长30%-50%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "健帆生物：预计2019年净利润同比增长30.0%-50%",
            "features": {
                "keywords": [
                    "健帆生物",
                    "2019年",
                    "净利润",
                    "同比增长",
                    "30.0%",
                    "50%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "健帆生物：预计2019年净利润同比增长30.0%-50%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "健帆生物(300529.SZ)：2019年净预增30%-50%",
            "features": {
                "keywords": [
                    "健帆生物",
                    "300529.SZ",
                    "2019年",
                    "净预增",
                    "30%",
                    "50%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "健帆生物(300529.SZ)：2019年净预增30%-50%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]